THOR-AABB Working Group

Transfusions play a key role in preventing deaths in traumatic shock and in other massively bleeding patients. The challenges and benefits of providing optimal transfusion support during the resuscitation of these patient are less well characterized than in stable patients. This workshop, organized by members of AABB and the THOR Network, will highlight use of current and next-generation interventions to improve transfusion support in these settings, and will address practical considerations in the implementation of better care strategies.

The THOR-AABB Working Group is having a one day symposium on hemorrhagic shock resuscitation.

THOR-AABB Working Group

  • Oct 12
  • 0800-1700
  • Boston

AGENDA OVERVIEW

BACK TO THE FUTURE WITH WHOLE BLOOD AND PLASMA

Epidemiology and Outcomes of Traumatic Hemorrhagic Shock
John Holcomb, MD, FACS
Professor, Department Of Surgery UT Health | The University of Texas Houston, TX

Pathophysiology and Consequences of Blood Failure
Nathan J. White, MD, MS
Assistant Professor of Emergency Medicine University of Washington
Seattle, WA

Pre-hospital Plasma and Whole Blood
Jason L. Sperry, MD, MPH
Assistant Professor of Surgery and Critical Care University of Pittsburgh
Pittsburgh, PA

Debate: What is the Clinical Relevance of Hyperfibrinolysis?
Hunter Moore, MD PhD
Chief Surgical Resident
University of Colorado Department of Surgery Denver, CO

COL Andrew P Cap, MD PhD
Medical Corps, US Army |Chief, Blood Research, US Army Institute of Surgical Research Associate Professor of Medicine, Uniformed Services University
Program Director, Clinical Research Fellowship | Staff Hematologist-Oncologist
San Antonio, TX

Risk and Benefits of Leukoreduction of Whole Blood with Platelet Sparing Filters
Philip C. Spinella, MD FCCM
Professor, Pediatrics
Director, Translational Research Program Division of Critical Care, Department Pediatrics Washington University in St Louis,
St Louis, MO USA

Plasma Incompatibility Risks in Patients with Blood Failure
Mark H. Yazer, MD
Professor of Pathology, University of Pittsburgh
Medical Director of the RBC Serology Laboratory at the Centralized Transfusion Pittsburgh, PA, USA

Debate: Should Plasma Be Used as a Volume Expander?
Donald Jenkins, MD
Vice Chair for Quality, Department of Surgery
University of Texas Health Science Center at San Antonio San Antonio, TX USA

Simon Stanworth, MA, FRCP (Paeds, UK), PhD, FRCPath
Consultant Haematologist
NHS Blood and Transplant and Oxford Radcliffe Hospitals NHS Trust UK

WHAT’S COLD IS HOT

Cold Platelet Norway Trial Data
Geir Strandenes, MD
Senior Anesthetist
Dept of War Surgery and Emergency Medicine
Norwegian Armed Forces Medical Services Bergen, Norway

Cold Platelet Storage Solutions
Jose A. Cancelas Perez, MD, PhD
Director, Research Division and Medical Director for Cell Therapies
Hoxworth Blood Center Deputy Director, Hoxworth Blood Center
Professor, UC Department of Pediatrics Cincinnati Children’s Hospital
Cinicnnati, OH, USA

Temperature Cycling of Platelets
Jaro Vostal, MD, PhD
Chief, Laboratory of Cellular Hematology
Division of Hematology (DH) Office of Blood Research and Review (OBRR)
FDA

DEALERS CHOICE?

Fibrinogen Concentrates or 5 Day PRT Treated Cryoprecipitate
Melissa Cushing, MD
Associate Professor, Weill Cornell Medicine New York-Presbyterian Hospital
NY, NY

BLOOD FAR FORWARD

Improved Survival with Early Pre-Hospital RBC Transfusion
COL Jennifer M. Gurney, MD, FACS
Assistant Professor of Surgery
United States Uniformed Services University
US Army Joint Trauma System
USA

Advances in Oxygen Carriers
Allan Doctor, MD
Professor of Pediatrics, Critical Care Medicine
Associate Professor, Biochemistry & Molecular Biophysics
Washington University in St. Louis
St Louis, MO

DCR FOR WOMEN AND CHILDREN

Obstetric Damage Control Resuscitation
Alan Frankfurt, MD
Staff Anesthesiologist
Texas Health Resources Dallas, TX

FDA VISION

Future Path of the Center for Biologics Evaluation and Research at FDA
Peter Marks, MD, PhD
Director
Center for Biologics Evaluation and Research
U.S. Food and Drug Administration
10903 New Hampshire Avenue
WO71-7232
Silver Spring, MD 20993